search
Company Information
EUR
91.85
0.7 (0.8%)
BER:SNW, SANOFI SA
Industry: Drug Manufacturers - General
End of Day: 27 March 2024 GMT+0
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 15% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Address

46, avenue de la Grande Armée

Classification

Sector

Healthcare

Industry Group

Drug Manufacturers

Industry

Drug Manufacturers - General

Key Executives

Ms. Lise Kingo
Director
Mr. Olivier Charmeil
Executive VP, Divisional
Mr. Paul Hudson
CEO/Director
Ms. Fabienne Lecorvaisier
Director
Mr. Patrick Kron
Director
Mr. Frederic Oudea
Chairman of the Board/Director
Mr. Gilles Schnepp
Director
Mr. Jean-Baptiste Chasseloup De Chatillon
CFO/Executive VP
Ms. Diane Souza
Director
Mr. Thomas Sudhof
Director
Mr. Christophe Babule
Director
Ms. Rachel Duan
Director
Ms. Carole Ferrand
Director
Dr. Antoine Yver, M.D.,M.Sc.
Director
Ms. Natalie Bickford
Executive VP/Other Executive Officer
Ms. Julie Van Ongevalle
Executive VP, Divisional
Mr. Thomas Triomphe
Executive VP, Divisional
Mr. Brendan O'Callaghan
Executive VP, Divisional
Mr. Roy Papatheodorou
Executive VP/General Counsel
Mr. Wolfgang Laux
Director
Ms. Barbara Lavernos
Director
Mr. Yann Tran
Director
Mr. Emile Voest
Director
Ms. Madeleine Roach
Executive VP, Divisional
Mr. Emmanuel Frenehard
Executive VP/Other Executive Officer
Mr. Brian Foard
Executive VP, Divisional
Mr. Houman Ashrafian
Executive VP/Other Corporate Officer

Ownership

Institution Holdings

Dodge & Cox
78,250,193 (3.127%)
FMR Inc
20,379,166 (0.814%)
Fisher Asset Management, LLC
14,326,620 (0.572%)
Boston Partners Global Investors, Inc
13,032,746 (0.521%)
BlackRock Inc
10,293,655 (0.411%)
Bank of America Corp
10,192,559 (0.407%)
Morgan Stanley - Brokerage Accounts
7,868,480 (0.314%)
Fidelity Management & Research Company LLC
7,862,910 (0.314%)
Amvescap Plc.
6,919,101 (0.276%)
Bank of New York Mellon Corp
6,203,431 (0.248%)

Funds Holdings

JHancock Disciplined Value Fund
4,675,365 (0.187%)
Invesco Large Cap Value
3,577,355 (0.143%)
CREF Stock Account
1,963,148 (0.078%)
Robeco BP US Premium Equities
1,640,093 (0.066%)
Boston Partners Large Cap Value Equity
1,575,516 (0.063%)
Pictet Biopharmaceutical Mother
1,133,300 (0.045%)
American Century Equity Income Fund
1,032,383 (0.041%)
American Century US Value Yield Tr
1,032,383 (0.041%)
BGF US Flexible Equity Fund
941,806 (0.038%)
BlackRock Large Cap Focus Value Fund
880,292 (0.035%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices